Clinical trial design and new therapies for pulmonary arterial hypertension

Until 20 years ago the treatment of pulmonary arterial hypertension (PAH) was based on case reports and small series, and was largely ineffectual. As a deeper understanding of the pathogenesis and pathophysiology of PAH evolved over the subsequent two decades, coupled with epidemiological studies de...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Respir J
Asıl Yazarlar: Sitbon, Olivier, Gomberg-Maitland, Mardi, Granton, John, Lewis, Michael I., Mathai, Stephen C., Rainisio, Maurizio, Stockbridge, Norman L., Wilkins, Martin R., Zamanian, Roham T., Rubin, Lewis J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: European Respiratory Society 2019
Konular:
Series
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351342/
https://ncbi.nlm.nih.gov/pubmed/30545975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01908-2018
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller